European Journal of Molecular & Clinical Medicine

Abstract

Polycystic ovary syndrome (PCOS) is one of the most common endocrine disorders in women of reproductive age group¹. It affects 8.0% to 20.0% of women between 18-44 years of age worldwide².According to the National Institutes of Health Office of Disease Prevention, approximately 5 million women of childbearing age are affected by PCOS in United States.
 It is a heterogenous, multifactorial disorder with genetic and environmental etiology. The genetic component of PCOS is inherited from either parents in an autosomal dominant fashion. It is considered as a systemic and metabolic disorder associated with increased risk of cardiovascular diseases and type II diabetes mellitus resulting from associated hyperglycemia and insulin resistance.